Vor Biopharma Inc. (VOR) Earnings
Vor Biopharma Inc. is expected to report next earnings on November 12, 2026 (in NaN days), with a consensus EPS estimate of $-0.81. VOR has beaten EPS estimates in 3 of its last 12 reported quarters (average surprise -19.6% over the last four).
Next earnings
Nov 12, 2026in NaN days
EPS est $-0.81 · Revenue est —
Track record
Beat EPS in 3 of 12 quarters
Avg surprise -19.6% (last 4 quarters)
Earnings history
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| Aug 11, 2026 | $-0.69 | $-1.16 | -68.1% | — | — |
| May 13, 2026 | $-0.75 | $-0.73 | +2.7% | — | — |
| Nov 13, 2025 | $-3.06 | $-3.33 | -8.8% | — | — |
| May 14, 2025 | $-0.25 | $-0.26 | -4.0% | — | — |
| Mar 20, 2025 | $-0.34 | $-0.44 | -29.4% | — | — |
| Nov 7, 2024 | $-0.40 | $-0.40 | +0.0% | — | — |
| Aug 8, 2024 | $-0.41 | $-0.41 | +0.0% | — | — |
| May 9, 2024 | $-0.37 | $-0.45 | -21.6% | — | — |
| Mar 20, 2024 | $-0.49 | $-0.39 | +20.4% | $12M | — |
| Aug 10, 2023 | $-0.42 | $-0.45 | -7.1% | — | — |
| May 11, 2023 | $-0.38 | $-0.43 | -13.2% | — | — |
| Mar 23, 2023 | $-0.56 | $-0.53 | +5.4% | — | — |
Source: company filings + earnings calendar. For informational purposes only — not investment advice.